Olema Pharmaceuticals, Inc.
OLMA· Nasdaq
Olema Pharmaceuticals, Inc.
- Last sale
- Oct 1, 2026 · -4.46%
- Market cap
- $722.29M
- 87.5M shares
- Filings
- 560
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $157,697,000 | reported | |
| FY 2024 | 2024-12-31 | $124,517,000 | reported | |
| FY 2023 | 2023-12-31 | $86,140,000 | reported | |
| FY 2022 | 2022-12-31 | $82,274,000 | reported | |
| FY 2021 | 2021-12-31 | $51,100,000 | reported | |
| FY 2020 | 2020-12-31 | $13,704,000 | reported | |
| FY 2019 | 2019-12-31 | $3,920,000 | reported |
Olema Pharmaceuticals, Inc. · CIK 1750284 · Engraved from SEC EDGAR
